Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFABUTIN for Lymph node tuberculosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where RIFABUTIN was used for Lymph node tuberculosis.

Most Reported Side Effects for RIFABUTIN

Side Effect Reports % Deaths Hosp.
Drug ineffective 171 10.8% 52 52
Off label use 127 8.0% 6 29
Drug resistance 123 7.8% 14 27
Drug interaction 99 6.2% 6 36
Drug intolerance 97 6.1% 13 20
Pyrexia 95 6.0% 0 52
Drug reaction with eosinophilia and systemic symptoms 81 5.1% 2 58
Nausea 77 4.9% 0 34
Neutropenia 77 4.9% 0 35
Mycobacterium avium complex infection 76 4.8% 11 38
Treatment failure 64 4.0% 15 9
Vomiting 60 3.8% 1 41
Condition aggravated 59 3.7% 3 19
Immune reconstitution inflammatory syndrome 54 3.4% 1 20
Product use in unapproved indication 54 3.4% 2 18

Other Indications for RIFABUTIN

Mycobacterium avium complex infection (332) Tuberculosis (210) Mycobacterial infection (125) Product used for unknown indication (124) Atypical mycobacterial infection (113) Pulmonary tuberculosis (81) Disseminated tuberculosis (64) Disseminated mycobacterium avium complex infection (50) Tuberculosis of central nervous system (23) Helicobacter infection (22)

Other Drugs Used for Lymph node tuberculosis

ETHAMBUTOL (154) RIFAMPIN (147) ISONIAZID (142) PYRAZINAMIDE (126) LINEZOLID (41) MOXIFLOXACIN (36) LEVOFLOXACIN (30) ISONIAZID\PYRAZINAMIDE\RIFAMPIN (26) CLOFAZIMINE (25) BEDAQUILINE (20)

Related Pages

RIFABUTIN Full Profile All Lymph node tuberculosis Drugs RIFABUTIN Demographics RIFABUTIN Timeline